[HTML][HTML] Phase 3 trial of coronavir (favipiravir) in patients with mild to moderate COVID-19
TA Ruzhentsova, RA Oseshnyuk… - American journal of …, 2021 - ncbi.nlm.nih.gov
Favipiravir has demonstrated efficacy against the SARS-CoV-2 virus in several preliminary
studies. This study aimed to evaluate the efficacy and safety of favipiravir for treatment of …
studies. This study aimed to evaluate the efficacy and safety of favipiravir for treatment of …
Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
O Dyer - BMJ: British Medical Journal (Online), 2021 - search.proquest.com
An advisory panel of experts has voted by 13 to 10 to recommend that the US Food and
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …
Drug Administration should grant an emergency authorisation to Merck's molnupiravir …